POSTN and asthma: Sputum periostin was detectable in 44% of all samples analyzed using Assay A, and 90% of all samples using Assay B. Positive detection levels were similar in the mild-to-moderate (43% assay A, 88% assay B) and severe asthma (45% assay A, 93% assay B) groups.